Information  X 
Enter a valid email address

Broker Forecast - UBS issues a broker note on AstraZeneca PLC

By BFN News | 09:40 AM | Tuesday 29 October, 2019

UBS today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 5800p (from 5700p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t